علاج سرطان الخلايا الكبدية في المرحلة B وفق تصنيف BCLC (المرحلة المتوسطة)

References

• Patients with BCLC Stage B HCC should be treated with transarterial chemoembolization (Level 1, Strong Recommendation).
• AASLD advises radioembolization as an alternative therapy to chemoembolization in patients with BCLC Stage B HCC (Level 3, Strong Recommendation).
• Transarterial therapies should be performed in a selective/segmental fashion (over lobar treatment) whenever possible given a lower risk of hepatic dysfunction (Level 5, Strong Recommendation).
• Patients treated with TACE should undergo multiphase CT or contrast-enhanced MRI approximately 6 weeks after treatment, whereas those treated with TARE or EBRT should undergo imaging to assess response approximately 12 weeks after treatment.